FDA Inspection 904783 — Galena Biopharma, Inc.
The FDA completed an inspection of Galena Biopharma, Inc. on November 21, 2014 in San Ramon, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 21, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Ramon, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)